These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29276175)

  • 1. Impact of atrial fibrillation in patients with chronic kidney disease undergoing transcatheter aortic valve replacement: Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample.
    Cheung A; Lima FV; Yen TYM; Parikh P; Butler J; Gruberg L
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):21-25. PubMed ID: 29276175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
    Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chronic kidney disease in patients undergoing percutaneous or surgical carotid artery revascularization: Insights of the healthcare cost and utilization Project's National Inpatient Sample.
    Lima FV; Yen TY; Butler J; Yang J; Xu J; Gruberg L
    Cardiovasc Revasc Med; 2016 Dec; 17(8):560-565. PubMed ID: 27988086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital outcomes of transcatheter aortic valve replacement in patients with chronic and end-stage renal disease: a nationwide database study.
    Lorente-Ros M; Das S; Malik A; Romeo FJ; Aguilar-Gallardo JS; Fakhoury M; Patel A
    BMC Cardiovasc Disord; 2024 Jan; 24(1):21. PubMed ID: 38172786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Bandyopadhyay D; Sartori S; Baber U; Cao D; Chandiramani R; Tchétché D; Petronio AS; Mehilli J; Lefèvre T; Presbitero P; Capranzaro P; Sardella G; Van Mieghem NM; Chandrasekhar J; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Naber C; Kini A; Morice MC; Claessen BE; Chieffo A; Mehran R
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):198-207. PubMed ID: 31977142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of mitral stenosis on outcomes of aortic valve stenosis patient undergoing surgical aortic valve replacement or transcatheter aortic valve replacement.
    Al-Khadra Y; Darmoch F; Baibars M; Kaki A; Fanari Z; Alraies MC
    J Interv Cardiol; 2018 Oct; 31(5):655-660. PubMed ID: 29774601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry.
    Hansen JW; Foy A; Yadav P; Gilchrist IC; Kozak M; Stebbins A; Matsouaka R; Vemulapalli S; Wang A; Wang DD; Eng MH; Greenbaum AB; O'Neill WO
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2064-2075. PubMed ID: 29050623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
    Hengstenberg C; Chandrasekhar J; Sartori S; Lefevre T; Mikhail G; Meneveau N; Tron C; Jeger R; Kupatt C; Vogel B; Farhan S; Sorrentino S; Sharma M; Snyder C; Husser O; Boekstegers P; Hambrecht R; Widder J; Hildick-Smith D; De Carlo M; Wijngaard P; Deliargyris E; Bernstein D; Baber U; Mehran R; Anthopoulos P; Dangas G;
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1027-1037. PubMed ID: 28493641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of transcatheter aortic valve replacement in patients with and without atrial fibrillation: Insight from national inpatient sample.
    Khan MZ; Zahid S; Khan MU; Kichloo A; Jamal S; Minhas AMK; Ullah W; Sattar Y; Mir T; Balla S; Munir MB
    Expert Rev Cardiovasc Ther; 2021 Oct; 19(10):939-946. PubMed ID: 34605353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
    Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation.
    Lüders F; Kaier K; Kaleschke G; Gebauer K; Meyborg M; Malyar NM; Freisinger E; Baumgartner H; Reinecke H; Reinöhl J
    Clin J Am Soc Nephrol; 2017 May; 12(5):718-726. PubMed ID: 28289067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
    Patel AR; Dombrovskiy VY; Vogel TR
    Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C in risk prediction after transcatheter aortic valve replacement: a retrospective analysis.
    Kuwabara K; Zen K; Yashige M; Takamatsu K; Ito N; Kadoya Y; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
    ESC Heart Fail; 2022 Aug; 9(4):2601-2609. PubMed ID: 35661440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.